Αποτελέσματα Αναζήτησης
1 Ιαν 2017 · Foods such as added sugars, syrups, sweets, white bread and soft drinks are the main culprits. One case control study from Italy showed a positive association between GL and HCC overall and interestingly a stronger association was observed in patients with HBV and HCV[ 50 ].
- Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver ...
Compared with intake of 3 or fewer servings of...
- Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver ...
12 Απρ 2024 · Eating a nutritious and balanced diet that is rich in certain foods may help reduce a person’s risk of liver cancer. This article discusses some foods that may help reduce the risk of...
This review aims to discuss the role of dietary sugar in NAFLD pathogenesis, the health and economic burden, and the promising potential of sugar reduction to improve health outcomes for patients with this chronic liver disease.
8 Αυγ 2023 · In data reported here, there was a positive association between sugar-sweetened beverages and liver cancer (≥1 beverages/day vs ≤3 beverages/month, HR = 1.85) without significant difference between regular soft drinks and fruit drinks.
8 Αυγ 2023 · Compared with intake of 3 or fewer servings of sugar-sweetened beverages per month, those who consumed 1 or more servings per day had a significantly higher risk of liver cancer (18.0 vs 10.3 per 100 000 person-years [P value for trend = .02]; adjusted HR, 1.85 [95% CI, 1.16-2.96]; P = .01) and chronic liver disease mortality (17.7 vs 7.1 per ...
Chen H, Wang J, Li Z, Lam CWK, Xiao Y, Wu Q, et al. Consumption of sugar-sweetened beverages has a dose-dependent effect on the risk of non-alcoholic fatty liver disease: an updated systematic review and dose-response Meta-analysis.
Consumption of sugar-sweetened and artificially sweetened soft drinks and risk of obesity-related cancers. Public Health Nutrition 2018; 21(9):1618–1626. [PubMed Abstract] Stepien M, Duarte-Salles T, Fedirko V, et al. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.
